Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Biomedical Innovation topic
No spam. Unsubscribe anytime.
Committee advances bill updating Tennessee ’Right to Try’ for individualized investigational treatments
Summary
House Bill 192 would expand Tennessee’s Right to Try framework to cover individualized investigational treatments such as bespoke gene therapies; the committee approved the bill and sent it to calendar and rules.
House Bill 192, described by its sponsor as the Individualized Investigational Treatment Act, was advanced by the House Health Full Committee. The bill updates Tennessee’s Right to Try framework to explicitly include individualized treatments such as patient-specific gene therapies that have emerged since the 2015 and federal 2018 Right to Try acts.
The sponsor told the committee that science has evolved and state law should allow patients and physicians to pursue targeted individualized treatments under a parallel state pathway similar to existing Right to Try provisions. The bill’s backers said other states have revised statutes to permit individualized approaches and that Tennessee should follow suit to give patients with terminal or otherwise life‑threatening conditions an additional legal option.
There were no extended questions recorded in committee; the clerk recorded 16 ayes, 0 nos. The bill moves on to calendar and rules.
